SCHEMBL8801044

SCHEMBL8801044

CCOC(=O)C(CCSc1ccccc1)(C(=O)OCC)C(N)CCC(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.40
MAPT P10636 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
POLB P06746 1/20 0.36
LMNA P02545 2/20 0.36
GAA P10253 1/20 0.36
TSHR P16473 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
HPGD P15428 1/20 0.34
PIN1 Q13526 1/20 0.34
MMP8 P22894 1/20 0.33
ATM Q13315 1/20 0.33
AAK1 Q2M2I8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8801039 0.77 LTA4H (0.39) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL8633548 0.75 SLC7A5 (0.40) ALDH1A1NPC1RAB9ASMN1; SMN2POLB
SCHEMBL8803294 0.74 MMP8 (0.38) ALDH1A1SMN1; SMN2MMP8
SCHEMBL8329548 0.74 LTA4H (0.41) ALDH1A1MAPTPOLBLMNATSHR
SCHEMBL8799066 0.73 LMNA (0.39) SMN1; SMN2LMNAMMP8
SCHEMBL5428506 0.72 ALDH1A1 (0.50) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL12470718 0.72 ALDH1A1 (0.60) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL7516437 0.71 ALDH1A1 (0.54) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL8633153 0.71 CYP1A2 (0.33) POLBCYP1A2CYP2C19MMP8
SCHEMBL7445938 0.71 ALDH1A1 (0.49) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0792878-A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism Dompé S.P.A. (IT) 1997-09-03 EP disclosed